Condition: Glioblastoma Multiforme · Sponsor: BioTex, Inc.
The clinical investigation is a non-randomized, multicenter, open-label, prospective, exposure-time escalation clinical investigation. The clinical investigation is designed to assess the clinical safety and performance of the Oncomagnetic Device.
This description comes directly from the study's public registry record.
Ashok Gowda · 713-741-0111 · ashok@biotexmedical.com
Madeline Meier · 713-741-0111 · madeline.meier@biotexmedical.com
Always discuss trial participation with your own doctor first.
| Clinical Center Stuttgart | Stuttgart, Baden-Wurttemberg, Germany | Recruiting |
| Technical University of Munich | München, Bavaria, Germany | Recruiting |
| University Hospital Bonn | Bonn, North Rhine-Westphalia, Germany | Recruiting |
| Clinical Center Lünen | Lünen, North Rhine-Westphalia, Germany | Recruiting |
| University Hospital Leipzig | Leipzig, Saxony, Germany | Recruiting |
| Medical Center Mannheim | Mannheim, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06533163